Sigel A., Metal Ions in Biological Systems & Metal Ions in Life Sciences
Thompson, K. H.InEncyclopedia of Inorganic Chemistry;King, R. B., Ed.John Wiley & Sons Ltd.:Chichester, UK, 2011; Chapter 1, pp1–10.
Magner L. N., 2005, A History of Medicine, 2
Orvig C., 1999, Chem. Rev., 99, 2201, 10.1021/cr980419w
Thompson, K. H.; Orvig, C.InConcepts and Models in Bioinorganic Chemistry;Kraatz, H.B.; Metzler-Nolte, N., Eds.Wiley-VCH:Weinheim, Germany, 2006; Chapter 2, pp25–46.
Thompson K. H., 2003, Science, 300, 936, 10.1126/science.1083004
2013, Executive Summary: Medical Imaging in Canada 2012
Ehrlich P., 1912, Ber. Dtsch. Chem. Ges., 45, 756, 10.1002/cber.191204501110
Lloyd N. C., 2005, Angew. Chem., Int. Ed., 44, 941, 10.1002/anie.200461471
Chast, F.InThe Practice of Medicinal Chemistry,3rd ed.Wermuth, C. G.; Kubinyi, H., Eds.Academic Press, Elsevier Ltd.:London, UK, 2008, Chapter 1, pp3–62.
Rosenberg B., 1965, Nature, 205, 698, 10.1038/205698a0
Rosenberg B., 1969, Nature, 222, 385, 10.1038/222385a0
Alderden R. A., 2006, J. Chem. Educ., 83, 728, 10.1021/ed083p728
Hambley T. W., 2007, Science, 318, 1392, 10.1126/science.1150504
Kraatz H.-B., 2006, Concepts and Models in Bioinorganic Chemistry
Jones C. J., 2007, Medicinal Applications of Coordination Chemistry, 10.1039/9781847557759
Alessio E., 2011, Bioinorganic Medicinal Chemistry, 1, 10.1002/9783527633104
Dabrowiak J. C., 2009, Metals in Medicine, 10.1002/9780470684986
Farrell N. P., 1999, Uses of Inorganic Chemistry in Medicine, 1, 10.1039/9781847552242
Gielen M., 2005, Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine, 1, 10.1002/0470864052
Gaynor D., 2012, Dalton Trans., 41, 13239, 10.1039/c2dt31601c
Casini A., 2012, J. Inorg. Biochem., 109, 97, 10.1016/j.jinorgbio.2011.12.007
Guo Z., 1999, Angew. Chem., Int. Ed., 38, 1512, 10.1002/(SICI)1521-3773(19990601)38:11<1512::AID-ANIE1512>3.0.CO;2-Y
2009, Dalton Trans., 10629
Komeda S., 2012, Curr. Top. Med. Chem., 12, 219, 10.2174/156802612799078964
Farrell N. P., 2011, Curr. Top. Med. Chem., 11, 2623, 10.2174/156802611798040714
Ott I., 2009, Coord. Chem. Rev., 253, 1670, 10.1016/j.ccr.2009.02.019
2011, Dalton Trans., 40, 6057, 10.1039/c1dt90072b
Anderson C. J., 1999, Chem. Rev., 99, 2219, 10.1021/cr980451q
Bourassa M. W., 2012, Metallomics, 4, 721, 10.1039/c2mt20052j
Banerjee S., 2001, Semin. Nucl. Med., 31, 260, 10.1053/snuc.2001.26205
Cardinal Health.FDA-Approved Radiopharmaceuticals; Rev. 8 No. 6.5.13;http://www.cardinal.com/mps/wcm/connect/1bcdfc80447f1763b29ab77fc4070dc5/7COMPLI9958_FDA-approved_list_082412_v3.pdf?MOD=AJPERES(last accessed October 11, 2013) .
Nunn A. D., 2006, Invest. Radiol., 41, 206, 10.1097/01.rli.0000191370.52737.75
Josephson L., 2013, J. Nucl. Med., 54, 329, 10.2967/jnumed.112.107615
Batholomä M. D., 2010, Chem. Rev., 110, 2903, 10.1021/cr1000755
Banerjee S. R., 2005, Nucl. Med. Biol., 32, 1, 10.1016/j.nucmedbio.2004.09.001
Liu S., 1999, Chem. Rev., 99, 2235, 10.1021/cr980436l
Rösch F., 2013, Appl. Radiat. Isot., 76, 24, 10.1016/j.apradiso.2012.10.012
Breeman W. A. P., 2007, Eur. J. Nucl. Med. Mol. Imaging, 34, 978, 10.1007/s00259-007-0387-4
Eckert & Ziegler GmbH, Berlin;http://www.ezag.com(last accessed July 22, 2013) .
OctreoPharm Sciences GmbH, Berlin;http://www.octreopharmsciences.com(last accessed July 22, 2013) .
Rösch F., 2011, Dalton Trans., 40, 6104, 10.1039/c0dt01504k
World Health Organization, 2013, Cancer
Lippert B., 1999, Cisplatin - Chemistry and Biochemistry of a Leading Anticancer Drug, 1, 10.1002/9783906390420
Peyrone M., 1844, Ann. Chem. Pharm., 51, 1, 10.1002/jlac.18440510102
Rosenberg B., 1978, Interdiscip. Sci. Rev., 3, 134, 10.1179/030801878791926119
Rosenberg B., 1971, Platinum Met. Rev., 15, 42, 10.1595/003214071X1524251
Rosenberg B., 1973, Naturwissenschaften, 60, 399, 10.1007/BF00623551
Rosenberg, B.; VanCamp, L.; Krigas, T.Anti-Animal Tumor Method.U.S. Patent Office 4,177,263, 1979.
Eisenstein R. I., 2001, Nat. Biotechnol., 19, 881, 10.1038/nbt0901-881
Blumenstyk G., 1999, The Chronicles of Higher Education, 12, A39
Rosenberg, B.; VanCamp, L.; Krigas, T.Anti-Tumor Method. U.S. Patent Office 5,562,925, 1996.
Research Corp. Technologies, Inc. Patent Litigation, No. 97-2836 (D.N.J. Oct. 21, 1999), affirmed Research Corp. Techs., Inc. et al. v. Gensia Labs., Inc. et al., 10 Fed. Appx. 856 (Fed. Cir. 2001) .
Reedijk J., 1999, Chem. Rev., 99, 2499, 10.1021/cr980422f
Wang D., 2005, Nat. Rev. Drug Discovery, 4, 307, 10.1038/nrd1691
Berners-Price, S. J.; Appleton, T. G.InPlatinum-Based Drugs in Cancer Therapy;Kelland, L.; Farrell, N. P., Eds.Humana Press Inc.:Totowa, NJ, 2000; pp3–35.
Berners-Price S. J., 2006, Prog. Nucl. Magn. Reson. Spectrosc., 49, 65, 10.1016/j.pnmrs.2006.05.002
Cleare M. J., 1973, Bioinorg. Chem., 2, 187, 10.1016/S0006-3061(00)80249-5
Cleare M. J., 1973, Platinum Met. Rev., 17, 2, 10.1595/003214073X171213
Cleare, M. J.; Hoeschele, J. D.; Rosenberg, B.; VanCamp, L.Malonato platinum anti-tumor compounds. U.S. Patent Office 4,140,707, 1979.
Kidani Y., 1980, Gann, 71, 637
Kidani, Y.; Masahide, N.Cytostatic platinum organic complexes. U.S. Patent Office 4,710,577, 1987.
Charest G., 2013, J. Neurooncol., 115, 365, 10.1007/s11060-013-1238-8
Stathopoulos P. G., 2012, J. Drug Delivery Ther., 2, 106, 10.22270/jddt.v2i3.146
Boulikas T., 2009, Expert Opin. Invest. Drugs, 18, 1197, 10.1517/13543780903114168
Regulon Inc.:Athens;http://www.lipoplatin.com(last accessed October 04, 2013) .
Carr J. L., 2006, Cancer Chemother. Pharmacol., 57, 483, 10.1007/s00280-005-0069-5
Hall M. D., 2002, Coord. Chem. Rev., 232, 49, 10.1016/S0010-8545(02)00026-7
Farrell, N.; Spinelli, S.InUses of Inorganic Chemistry in Medicine;Farrell, N. P., Ed.Royal Society of Chemistry:Cambridge, UK, 1999, Chapter 8; pp124–134.
Hensing T. A., 2006, Anti-Cancer Drugs, 17, 697, 10.1097/01.cad.0000215054.62942.7f
Quiroga A. G., 2011, Curr. Top. Med. Chem., 11, 2613, 10.2174/156802611798040723
Kartalou M., 2001, Mutat. Res., 478, 23, 10.1016/S0027-5107(01)00141-5
Stewart D. J., 2007, Crit. Rev. Oncol. Hematol., 63, 12, 10.1016/j.critrevonc.2007.02.001
Kaiser J., 2011, Science, 331, 1542, 10.1126/science.331.6024.1542
Collery P., 1996, Anticancer Res., 16, 687
Nordenberg J., 1990, Eur. J. Cancer, 26, 905, 10.1016/0277-5379(90)90197-2
Niiki Pharma, Tampa (FL);http://www.niikipharma.com(last accessed July 22, 2013) .
Bergamo A., 2007, Dalton Trans., 1267, 10.1039/b617769g
Guidi F., 2013, J. Inorg. Biochem., 118, 94, 10.1016/j.jinorgbio.2012.10.003
Sava G., 2011, Dalton Trans., 40, 9069, 10.1039/c1dt10522a
Dwyer F. P., 1952, Nature, 170, 190, 10.1038/170190a0
Hartinger C. G., 2008, Chem. Biodiversity, 5, 2140, 10.1002/cbdv.200890195
Hartinger C. G., 2006, J. Inorg. Biochem., 100, 891, 10.1016/j.jinorgbio.2006.02.013
Chen S. J., 2011, Blood, 117, 6425, 10.1182/blood-2010-11-283598
Lo-Coco F., 2012, Paper No. 6
Garnier N., 2013, Leukemia, 27, 2220, 10.1038/leu.2013.54
Finlay I. G., 2005, Lancet Oncol., 6, 392, 10.1016/S1470-2045(05)70206-0
Ramogida C. F., 2013, Chem. Commun., 49, 4720, 10.1039/c3cc41554f
Volkert W. A., 1991, J. Nucl. Med., 32, 174
Smith N. A., 2013, Philos. Trans. R. Soc., A, 371, 20120519, 10.1098/rsta.2012.0519
Moore C. M., 2011, Lasers Surg. Med., 43, 768, 10.1002/lsm.21104
Pinnacle Biologics, Bannockburn, IL;http://www.photofrin.com(last accessed October 11, 2013) .
Stebabiotech SA, Luxembourg;http://www.stebabiotech.com(last accessed October 11, 2013) .
Gibaud, S.; Jaouen, G.InMedicinal Organometallic Chemistry;Jaouen, G.; Metzler-Nolte, N., Eds.Springer Verlag,Heidelberg, Germany, 2010; Chapter 1, pp1–20.
Patra M., 2012, Dalton Trans., 41, 6350, 10.1039/c2dt12460b
Breinl A., 1907, Br. Med. J., 1, 132, 10.1136/bmj.1.2403.132
Jolliffe D. M., 1993, JRSM, 86, 287, 10.1177/014107689308600515
World Health Organization, 2013, Trypanosomiasis, Human African (Sleeping Sickness)
Goodwin L. G., 1995, Trans. R. Soc. Trop. Med. Hyg., 89, 339, 10.1016/0035-9203(95)90572-3
World Health Organization, 2010, Control of Leishmaniasis
Olliaro P. L., 2005, Lancet Infect. Dis., 5, 763, 10.1016/S1473-3099(05)70296-6
Sun H., 2010, Biological Chemistry of Arsenic, Antimony and Bismuth, 10.1002/9780470975503
Janssen M. J. R., 2006, Neth. J. Med., 64, 191
Malfertheiner P., 2011, Lancet, 377, 905, 10.1016/S0140-6736(11)60020-2
De Boer W. A., 2000, Aliment. Pharmacol. Ther., 14, 85, 10.1046/j.1365-2036.2000.00686.x
Microbion Corp., Bozeman (MT);http://www.microbioncorp.com(last accessed July 22, 2013) .
Eckhardt S., 2013, Chem. Rev., 113, 4708, 10.1021/cr300288v
Aziz Z., 2012, Burns, 38, 307, 10.1016/j.burns.2011.09.020
Wasiak J., 2013, Cochrane Database of Systematic Rev.
Garner J. P., 2005, Burns, 31, 539, 10.1016/j.burns.2005.01.014
Garner J. P., 2005, Burns, 31, 379, 10.1016/j.burns.2004.12.001
Clinical Trials USA 2013; http://www.clinicaltrials.gov.
Domarle O., 1998, Antimicrob. Agents Chemother., 42, 540, 10.1128/AAC.42.3.540
Biot C., 2011, Parasite, 18, 207, 10.1051/parasite/2011183207
Viamet, Durham (NC);http://www.viamet.com(last accessed July 22, 2013) .
Majithia V., 2007, Am. J. Med., 120, 936, 10.1016/j.amjmed.2007.04.005
Forestier J., 1934, Lancet, 224, 646, 10.1016/S0140-6736(00)82169-8
Berners-Price, S. J.InBioinorganic Medicinal Chemistry;Alessio, E., Ed.Wiley-VCH:Weinheim, Germany, 2011; Chapter 7, pp197–222.
Benedek T. G., 2004, J. Hist. Med. Allied Sci., 59, 50, 10.1093/jhmas/jrg042
Gunatilleke S. S., 2008, J. Inorg. Biochem., 102, 555, 10.1016/j.jinorgbio.2007.10.019
1960, Ann. Rheum. Dis., 19, 95, 10.1136/ard.19.2.95
Messori, L.; Marcon, G.InMetal Ions in Biological Systems Vol 41: Metal Ions and Their Complexes in Medication;Sigel, A.; Sigel, H., Eds.Marcel Dekker Inc.:New York, 2004; Chapter 9, pp279–304.
Pope J. E., 2002, J. Rheumatol., 29, 255
Lehman A. J., 2005, Arthritis & Rheumatism, 52, 1360, 10.1002/art.21018
Walz D. T., 1983, Am. J. Med., 75, 90, 10.1016/0002-9343(83)90481-3
Thakor A. S., 2011, Nano Lett., 11, 4029, 10.1021/nl202559p
Nejrup K., 2008, Clin. Rheumatol., 27, 1363, 10.1007/s10067-008-0918-9
Lee S.-M., 2013, ACS Nano, 7, 50, 10.1021/nn301215q
Von Reis G., 1951, Acta Med. Scand. (Suppl.), 259, 27, 10.1111/j.0954-6820.1951.tb13229.x
Berglöf F. E., 1959, Acta Rheumatol. Scand., 5, 70
Bessant R., 2003, Rheumatology, 42, 1036, 10.1093/rheumatology/keg283
Sheppeard H., 1980, Rheumatol. Rehabil., 19, 25, 10.1093/rheumatology/19.1.25
Goldstein S., 2005, Free Radical Biol. Med., 38, 839, 10.1016/j.freeradbiomed.2004.10.027
World Health Organization, 2013, Diabetes
Willsky G. R., 2001, J. Inorg. Biochem., 85, 33, 10.1016/S0162-0134(00)00226-9
Lyonnet B. M., 1899, Presse Med., 7, 191
Josephson L., 1977, Biochemistry, 16, 4572, 10.1021/bi00640a006
Heyliger C. E., 1985, Science, 227, 1474, 10.1126/science.3156405
Rehder D., 1999, Coord. Chem. Rev., 182, 297, 10.1016/S0010-8545(98)00194-5
Cam M. C., 1993, Diabetes Res. Clin. Pract., 20, 111, 10.1016/0168-8227(93)90004-O
Thompson K. H., 2001, Coord. Chem. Rev., 219, 1033, 10.1016/S0010-8545(01)00395-2
McNeill J. H., 1992, J. Med. Chem., 35, 1489, 10.1021/jm00086a020
Melchior M., 2001, Inorg. Chem., 40, 4686, 10.1021/ic000984t
Thompson K. H., 2009, J. Inorg. Biochem., 103, 554, 10.1016/j.jinorgbio.2008.12.003
Thompson K. H., 2006, Dalton Trans., 761, 10.1039/B513476E
Thompson K. H., 2006, J. Inorg. Biochem., 100, 1925, 10.1016/j.jinorgbio.2006.08.016
CFM-Pharma, B. V.Rotterdam;http://www.cfmpharma.com(last accessed July 22, 2013) .
Wei Y.-B., 2012, BioMetals, 25, 1261, 10.1007/s10534-012-9587-x
Medesis Pharmaceuticals Inc.,Montreal;http://www.medesispharma.com(last accessed July 22, 2013) .
Muñoz M. C., 2001, Diabetes, 50, 131, 10.2337/diabetes.50.1.131
Claret M., 2005, Endocrinology, 146, 4362, 10.1210/en.2005-0385
Barbera A., 2001, Diabetologia, 44, 507, 10.1007/s001250100479
Hanzu F., 2010, Diabetes, Obes. Metab., 12, 1013, 10.1111/j.1463-1326.2010.01293.x
REDOX Pharmaceutical Corp., Greenvale, NY;http://www.redoxpharm.com(last accessed July 22, 2013) .
Schwartz J. A., 2001, J. Virol., 75, 4117, 10.1128/JVI.75.9.4117-4128.2001
Louie A. Y., 1998, Proc. Natl. Acad. Sci. U.S.A., 95, 6663, 10.1073/pnas.95.12.6663
Rozenbaum W., 1985, Lancet, 325, 450, 10.1016/S0140-6736(85)91162-6
Stephan H., 2013, Eur. J. Inorg. Chem., 2013, 1585, 10.1002/ejic.201201224
Dan K., 2002, Pharmacol. Res., 46, 357, 10.1016/S1043661802001706
Zhang H., 2012, Bioorg. Med. Chem. Lett., 22, 1664, 10.1016/j.bmcl.2011.12.115
Yamase T., 2005, J. Mater. Chem., 15, 4773, 10.1039/b504585a
De Clercq E., 2003, Nat. Rev. Drug Discovery, 2, 581, 10.1038/nrd1134
Eickhoff T. C., 2002, Vaccine, 20, S1, 10.1016/S0264-410X(02)00163-9
“Minamata” Convention Agreed by Nations – Global Mercury Agreement to Lift Health Threats from Lives of Millions World-Wide;http://www.unep.org/newscentre.default.aspx?DocumentID2702&ArticleID9373(last accessed July 22, 2013) andhttp://www.mercuryconvention.org(last accessed November 08, 2013).
The Micronutrient Initiative, Ottawa;http://www.micronutrient.org(last accessed July 22, 2013) .
Andersen O., 2004, Mini-Rev. Med. Chem., 4, 11, 10.2174/1389557043487583
Harrison O., 2013, Vitamin & Supplement Manufacturing in the U.S.
NCT 00001262, Clinical Trials USA 2013;http://www.clinicaltrials.gov(last accessed July 22, 2013) .
Ganite; FDA-approved label, 2003.
Bouillon R., 1991, Am. J. Med., 90, 107, 10.1016/0002-9343(91)90512-V
Jonville-Bera A.-P., 2011, Presse Med., 40, 453, 10.1016/j.lpm.2011.07.010
European Medicines Agency. European Medicines Agency confirms positive benefit-risk balance of Protelos/Osseor, but recommends new contraindications and revised warnings; Press release March 16, 2012; http://www.ema.europa.eu.
European Medicines Agency. Recommendation to restrict the use of Protelos/Osseor (Strontium ranelate); Press release April 26, 2013; http://www.ema.europa.eu.
Tinker J. H., 1976, Anestesiology, 45, 340, 10.1097/00000542-197609000-00016
de C. Pereira A., 2011, Nitric Oxide, 24, 192, 10.1016/j.niox.2011.03.001
Wecksler S. R., 2007, Inorg. Chem., 46, 395, 10.1021/ic0607336
Silva J. J. N., 2007, Br. J. Pharmacol., 152, 112, 10.1038/sj.bjp.0707363
Cameron B. R., 2003, Inorg. Chem., 42, 4102, 10.1021/ic020283r
Inagi, R.InFrontiers in Cardiovascular Drug Discovery;Rahman, A.u.; Choudhary, M. I., Eds.Bentham Science Publishers Ltd.:Sharjah, 2010; Vol.1, pp138–153.
Batinić-Haberle I., 2010, Antioxid. Redox Signaling, 13, 877, 10.1089/ars.2009.2876
Cuzzocrea S., 2004, FASEB J., 18, 94, 10.1096/fj.03-0428com
Friedel F. C., 2012, J. Inorg. Biochem., 109, 26, 10.1016/j.jinorgbio.2011.12.008
Wang Z.-Q., 2004, J. Pharmacol. Exp. Ther., 309, 869, 10.1124/jpet.103.064154
Birch N. J., 1999, Chem. Rev., 99, 2659, 10.1021/cr9804240
Price L. H., 1994, N. Engl. J. Med., 331, 591, 10.1056/NEJM199409013310907
McCarthy M. J., 2010, Pharmacogenomics, 11, 1439, 10.2217/pgs.10.127
Duffy A., 2002, J. Clin. Psychiatry, 63, 1171, 10.4088/JCP.v63n1213
Grof P., 2002, J. Clin. Psychiatry, 63, 942, 10.4088/JCP.v63n1013
Malhi G. S., 2013, CNS Drugs, 27, 135, 10.1007/s40263-013-0039-0
Hajek T., 2014, Psychol. Med, 44, 507, 10.1017/S0033291713001165
Pouladi M. A., 2012, Neurobiol. Dis., 48, 282, 10.1016/j.nbd.2012.06.026
Blindauer C., 2012, Biochem. Mag., 34, 4, 10.1042/BIO03405004
Andersen O., 1999, Chem. Rev., 99, 2683, 10.1021/cr980453a
Bickel H., 1960, Helv. Chim. Acta, 43, 2129, 10.1002/hlca.19600430732
Coburn J. W., 1993, Nefrologia (Suppl. 3), 13, 123
Flora S. J., 2007, Cell Mol. Biol., 53, 26
Cappellini M. D., 2006, Blood, 107, 3455, 10.1182/blood-2005-08-3430
Giardini C., 1997, Curr. Opin. Hematol., 4, 79, 10.1097/00062752-199704020-00002
Cohen A. R., 2003, Blood, 102, 1583, 10.1182/blood-2002-10-3280
de Bie P., 2007, J. Med. Genet., 44, 673, 10.1136/jmg.2007.052746
Alvarez H. M., 2010, Science, 327, 331, 10.1126/science.1179907
Brewer G. J., 2003, Arch. Neurol., 60, 379, 10.1001/archneur.60.3.379
World Health Organization, 2012, Dementia
Lesage S., 2009, Hum. Mol. Genet., 18, R48, 10.1093/hmg/ddp012
Scott L. E., 2009, Chem. Rev., 109, 4885, 10.1021/cr9000176
Telpoukhovskaia M. A., 2013, Chem. Soc. Rev., 42, 1836, 10.1039/C2CS35236B
Badrick A. C., 2011, Curr. Top. Med. Chem., 11, 543, 10.2174/156802611794785181
Sharpe P. C., 2011, Curr. Top. Med. Chem., 11, 591, 10.2174/156802611794785163
Bareggi S. R., 2012, CNS Neurosci. Ther., 18, 41, 10.1111/j.1755-5949.2010.00231.x
Ritchie C. W., 2003, Arch. Neurol., 60, 1685, 10.1001/archneur.60.12.1685
Lannfelt L., 2008, Lancet Neurol., 7, 779, 10.1016/S1474-4422(08)70167-4
Prana Biotechnology Limited, Parkville (VIC);http://www.pranabio.com(last accessed July 22, 2013) .
Relkin N. R., 2008, Lancet Neurol., 7, 762, 10.1016/S1474-4422(08)70168-6
Moe S., 2006, Kidney Int., 69, 1945, 10.1038/sj.ki.5000414
Bover J., 2009, Blood Purif., 27, 369, 10.1159/000209250
2003, Am. J. Kidney Dis. (Supp. 3), 42, S1
Mehrotra R., 2008, Clin. J. Am. Soc. Nephrol., 3, 1437, 10.2215/CJN.04741107
Awah N. W., 2012, Clin. Infect. Dis., 54, 1145, 10.1093/cid/cis020
Menendez C., 1997, Lancet, 350, 844, 10.1016/S0140-6736(97)04229-3
Smith H. J., 2003, Cochrane Database of Systematic Rev., 10.1002/14651858.CD004910.pub3
Driggers E. M., 2008, Nat. Rev. Drug Discovery, 7, 608, 10.1038/nrd2590
De Clercq E., 2010, Pharmacol. Therap., 128, 509, 10.1016/j.pharmthera.2010.08.009
Mann B. S., 2007, The Oncologist, 12, 1247, 10.1634/theoncologist.12-10-1247
Sun H., 2010, Annu. Rep. Prog. Chem., Sect. A: Inorg. Chem., 106, 20, 10.1039/b920672h
Mounicou S., 2009, Chem. Soc. Rev., 38, 1119, 10.1039/b713633c
Szpunar J., 2005, Analyst, 130, 442, 10.1039/b418265k
Harford C., 1997, Acc. Chem. Res., 30, 123, 10.1021/ar9501535
Sankararamakrishnan R., 2005, Proteins, 58, 211, 10.1002/prot.20265
Solomon E. I., Chem. Rev.
de Almeida A., 2013, Coord. Chem. Rev., 257, 2689, 10.1016/j.ccr.2013.01.031
Barry N. P. E., 2013, Chem. Commun., 49, 5106, 10.1039/c3cc41143e
Barry N. P. E., 2013, ACS Nano, 7, 5654, 10.1021/nn403220e
Sava G., 2012, Dalton Trans., 41, 8226, 10.1039/c2dt30075c
Navarro M., 2010, Drug Discovery Today, 15, 1070, 10.1016/j.drudis.2010.10.005
Berthron G., 1995, Handbook of Metal-Ligand Interactions in Biological Fluids, 1
Groessl M., 2011, Curr. Top. Med. Chem., 11, 2632, 10.2174/156802611798040705
Parker L. J., 2012, J. Inorg. Biochem., 115, 138, 10.1016/j.jinorgbio.2012.02.015
Petković M., 2011, Metallomics, 3, 550, 10.1039/c0mt00096e
Meermann B., 2012, Anal. Bioanal. Chem., 403, 1501, 10.1007/s00216-012-5915-9
Bytzek A. K., 2012, Electrophoresis, 33, 622, 10.1002/elps.201100402
Rodríguez-Rodríguez C., 2012, Coord. Chem. Rev., 256, 2308, 10.1016/j.ccr.2012.03.008
Wong, G. T.Alzheimer Research Forum; August 28, 2007; http://www.alzforum.org/new/detail.asp?id=1647(last accessed July 22, 2013) .
Meggers E., 2007, Curr. Opin. Chem. Biol., 11, 287, 10.1016/j.cbpa.2007.05.013
Storr T., 2006, Chem. Soc. Rev., 35, 534, 10.1039/b514859f
Meggers E., 2009, Chem. Commun., 1001, 10.1039/b813568a
Huang R., 2005, Biochem. Pharmacol., 69, 1009, 10.1016/j.bcp.2005.01.001
Meggers E., 2009, Dalton Trans., 10882, 10.1039/b917792b
Bullock A. N., 2009, PLoS One, 4, e7112, 10.1371/journal.pone.0007112
Süss-Fink G., 2010, Dalton Trans., 39, 1673, 10.1039/B916860P
Aird R. E., 2002, Br. J. Cancer, 86, 1652, 10.1038/sj.bjc.6600290
Bergamo A., 2010, J. Inorg. Biochem., 104, 79, 10.1016/j.jinorgbio.2009.10.005
Scolaro C., 2005, J. Med. Chem., 48, 4161, 10.1021/jm050015d
Ratanaphan A., 2010, Chem. Biodiversity, 7, 1290, 10.1002/cbdv.200900288
Romero-Canelón I., 2013, Inorg. Chem., 52, 12276, 10.1021/ic400835n
Casini A., 2012, Chem. Sci., 3, 3135, 10.1039/c2sc20627g
Harris W. R., 1990, Inorg. Chem., 29, 119, 10.1021/ic00326a024
Campbell R. F., 1977, J. Biol. Chem., 252, 5996, 10.1016/S0021-9258(17)40019-6
Zak O., 1988, Biochemistry, 27, 1075, 10.1021/bi00403a033
Albert A., 1985, Selective Toxicity - The Physico-chemical Basis of Therapy, 7, 10.1007/978-94-009-4846-4
Huttunen K. M., 2011, Curr. Top. Med. Chem., 11, 2265, 10.2174/156802611797183230
Sharma V., 1999, Chem. Rev., 99, 2545, 10.1021/cr980429x
Salas P. F., 2013, Chem. Rev., 113, 3450, 10.1021/cr3001252
Gasser G., 2011, J. Med. Chem., 54, 3, 10.1021/jm100020w
Wyatt P. G., 2011, Curr. Top. Med. Chem., 11, 1275, 10.2174/156802611795429185
Collins I., 2006, Nat. Chem. Biol., 2, 689, 10.1038/nchembio840
Gunaratna C., 2000, Curr. Sep. Drug Dev., 19, 17
Lipinski C. A., 2001, Adv. Drug Delivery Rev., 46, 3, 10.1016/S0169-409X(00)00129-0
Fricker S. P., 2007, Dalton Trans., 4903, 10.1039/b705551j
Baes C. J., 1986, The Hydrolysis of Cations
Harris W. R., 1979, J. Am. Chem. Soc., 101, 6097, 10.1021/ja00514a037
Pritchard J. F., 2003, Nat. Rev. Drug Discovery, 2, 542, 10.1038/nrd1131
Sanchez-Cano C., 2009, Dalton Trans., 10702, 10.1039/b912708a
Johnstone T. C., 2013, ACS Nano, 7, 5675, 10.1021/nn401905g
Stathopoulos G. P., 2011, Cancer Chemother. Pharmacol., 68, 945, 10.1007/s00280-011-1572-5
Stathopoulous G. P., 2006, Anticancer Res., 26, 1489
Arrowsmith J., 2013, Nat. Rev. Drug Discovery, 12, 569, 10.1038/nrd4090
Vincent, J.InThe Bioinorganic Chemistry of Chromium;Vincent, J., Ed.John Wiley & Sons Ltd.:Chichester, UK, 2013; Chapter 2, pp7–30.
Functional metal complexes that bind to biomolecules. Action CM1105 (2012–2016);http://www.cm1105.eu(last accessed July 22, 2013) .
Theophrast von Hohenheim P., 1915, Sieben Defensiones (Antwort auf etliche Verunglimpfungen seiner Misgönner)
Bertrand G., 1912, 8th Int. Congr. Appl. Chem., 28, 30
